Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
01 1Farmhispania, S.A. Montmeló ES
02 1ALEMBIC PHARMACEUTICALS LIMITED Vadodara IN
03 1CIPLA LIMITED Mumbai IN
04 1HETERO LABS LIMITED Hyderabad IN
05 1MAC CHEM PRODUCTS (INDIA) PVT. LTD. Mumbai IN
06 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN
07 1NATCO PHARMA LIMITED Hyderabad IN
08 1SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou City CN
09 1SICHUAN XIELI PHARMACEUTICAL CO., LTD. Pengzhou CN
10 1SYNTHON BV Nijmegen NL
11 1Wisdom Pharmaceutical Co., Ltd. Haimen CN
12 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai CN
13 1Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City CN
01 11Gefitinib
02 1Gefitinib, Form-I
03 1Gefitinib, Micronised
01 5China
02 6India
03 1Netherlands
04 1Spain
01 12Valid
02 1Withdrawn by Holder
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
Certificate Number : R1-CEP 2016-305 - Rev 00
Status : Valid
Issue Date : 2022-10-06
Type : Chemical
Substance Number : 2866
Certificate Number : R1-CEP 2017-002 - Rev 00
Status : Valid
Issue Date : 2023-03-24
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2018-031 - Rev 01
Status : Valid
Issue Date : 2024-10-14
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2016-227 - Rev 02
Status : Valid
Issue Date : 2024-01-23
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2017-244 - Rev 02
Status : Valid
Issue Date : 2024-02-07
Type : Chemical
Substance Number : 2866
Certificate Number : CEP 2017-028 - Rev 01
Status : Valid
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 2866
Certificate Number : R0-CEP 2018-281 - Rev 00
Status : Valid
Issue Date : 2020-02-24
Type : Chemical
Substance Number : 2866
Certificate Number : R1-CEP 2016-154 - Rev 00
Status : Valid
Issue Date : 2022-06-07
Type : Chemical
Substance Number : 2866
Certificate Number : R1-CEP 2016-241 - Rev 00
Status : Valid
Issue Date : 2022-11-08
Type : Chemical
Substance Number : 2866
Certificate Number : R0-CEP 2018-236 - Rev 01
Status : Valid
Issue Date : 2022-02-02
Type : Chemical
Substance Number : 2866
A Gefitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gefitinib, including repackagers and relabelers. The FDA regulates Gefitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gefitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gefitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gefitinib supplier is an individual or a company that provides Gefitinib active pharmaceutical ingredient (API) or Gefitinib finished formulations upon request. The Gefitinib suppliers may include Gefitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Gefitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gefitinib CEP of the European Pharmacopoeia monograph is often referred to as a Gefitinib Certificate of Suitability (COS). The purpose of a Gefitinib CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Gefitinib EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Gefitinib to their clients by showing that a Gefitinib CEP has been issued for it. The manufacturer submits a Gefitinib CEP (COS) as part of the market authorization procedure, and it takes on the role of a Gefitinib CEP holder for the record. Additionally, the data presented in the Gefitinib CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Gefitinib DMF.
A Gefitinib CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Gefitinib CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Gefitinib suppliers with CEP (COS) on PharmaCompass.
We have 13 companies offering Gefitinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
